AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 4 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $548 | -19.9% | 11,413 | +1.5% | 0.01% | -20.0% |
| Q2 2023 | $684 | +58.3% | 11,245 | -2.3% | 0.02% | +50.0% |
| Q1 2023 | $432 | +32.9% | 11,504 | -0.9% | 0.01% | +25.0% |
| Q4 2022 | $325 | -99.9% | 11,611 | +2.9% | 0.01% | -11.1% |
| Q3 2022 | $317,000 | -18.1% | 11,281 | +1.2% | 0.01% | -10.0% |
| Q2 2022 | $387,000 | – | 11,152 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |